The Path to Diagnosis of Severe Asthma-A Qualitative Exploration
Sharon Davis,Biljana Cvetkovski,Gregory Katsoulotos,Joy Lee,Janet Rimmer,Natasha Smallwood,Katrina Tonga,Penelope Abbott,Sinthia Bosnic-Anticevich
DOI: https://doi.org/10.2147/ijgm.s435347
IF: 2.145
2024-08-20
International Journal of General Medicine
Abstract:Sharon R Davis, 1 Biljana Cvetkovski, 1 Gregory Peter Katsoulotos, 2, &ast Joy W Lee, 3, &ast Janet Rimmer, 4, &ast Natasha Smallwood, 3, &ast Katrina O Tonga, 5, &ast Penelope Abbott, 6 Sinthia Z Bosnic-Anticevich 1, 7 1 Woolcock Institute of Medical Research, Macquarie Park, NSW, Australia; 2 School of Medicine, Sydney Campus, The University of Notre Dame, Sydney, NSW, Australia; 3 Department of Respiratory Medicine, Alfred Hospital, Melbourne, VIC, Australia; 4 Department of Respiratory Medicine, St Vincent's Hospital, Darlinghurst, NSW, Australia; 5 Respiratory Department, Westmead Hospital, Westmead Clinical School, Faculty of Medicine & Health, University of Sydney, Sydney, NSW, Australia; 6 School of Medicine, Western Sydney University, Penrith, NSW, Australia; 7 Macquarie Medical School, Macquarie University, Macquarie Park, NSW, Australia &astThese authors contributed equally to this work Correspondence: Biljana Cvetkovski, Email Purpose: Severe asthma poses a significant health burden in those with the disease, therefore a timely diagnosis can ensure patients receive specialist care and appropriate medication management. This study qualitatively explored the patient experience of adult Australians with severe asthma regarding specialist referral, to identify potential opportunities to streamline the process of severe asthma diagnosis and treatment and optimise referral pathways. Patients and Methods: Adults currently being treated with medication for severe asthma were invited to participate in this study. Participants were interviewed and asked to describe initial diagnosis of their asthma or severe asthma, and how they came to be referred to secondary care. Interviews were transcribed verbatim, coded by two members of the research team and thematically analysed. Results: Thirty-two people completed the study; 72% were female. Mean interview length was 33 minutes. The major themes generated were patient-related factors contributing to seeking a severe asthma diagnosis; perceptions of health care provision; diagnosis of severe asthma and the referral journey. Key findings were that both patient and healthcare provider attitudes contributed to participants' willingness to seek or receive a referral, and referral to respiratory specialists was often delayed. Contributing factors included a mismatch between patient expectations and general practice, lack of continuity of primary care, and a lack of patient understanding of the role of the respiratory specialist. Conclusion: Timely severe asthma diagnosis in Australia appears to be hampered by an absence of a clear referral process, lack of general practitioner (GP) knowledge of additional treatment options, underutilisation of pharmacists, and multiple specialists treating patient comorbidities. Directions for future research might include interviewing healthcare providers regarding how well the referral process works for severe asthma patients, and researching the time between referral and when a patient sees the respiratory specialist. Keywords: respiratory, patient, referral, diagnosis, comorbidities Severe asthma is defined as asthma that remains uncontrolled despite regular treatment with high-dose inhaled corticosteroids plus long-acting beta2 agonist or with maintenance oral corticosteroids (GINA Step 4 level treatment), or asthma that requires this level of treatment to prevent it from becoming uncontrolled 1 and after optimisation of possible contributing factors including medication adherence and associated comorbidities. It is estimated that between 3% and 10% of people with asthma have severe disease. 2 Severe asthma is associated with high morbidity and mortality and poses an economic burden on both individuals and society. 3,4 People with severe asthma also experience a significant health burden as a result of their asthma, with an increased rate of hospitalisation, daily symptoms resulting in poor quality of life and often, poor functionality. 4,5 There has been a recent focus on acknowledging heterogeneity within asthma and the clinical manifestation of different phenotypes and treatable traits. 6,7 This adds complexity to the diagnosis and management of asthma- in particular for individuals with severe asthma. Due to symptom severity and the complex nature of this heterogeneity, the management of severe asthma in Australia is primarily undertaken by specialist respiratory physicians working in tertiary health care settings. This approach facilita -Abstract Truncated-
medicine, general & internal